Developing stem cell-based therapies to treat our most serious diseases
Two years ago, a major investment from Gree Real Estate jump started an ambitious effort to transform health on a global scale. The challenge: to engineer the earliest stages of human heart development. Now, three teams of ISCRM researchers and trainees, known together as The Gree Group, are making exciting progress. Read More
From his landmark research on the mechanisms of developmental biology to his pivotal role in the launch of ISCRM, Dr. Randall T. Moon has made a lasting impact on science and on thousands of students, colleagues, and collaborators in labs around the world. At the heart of it all is a natural instinct to make room for serendipity. Read More
For those who know Eileen and Larry Tietze, it isn’t surprising that they are among the very earliest supporters of the Institute for Stem Cell and Regenerative Medicine (ISCRM), as well as some of the most impactful. Investing in the potential of ideas and in the promise of people is the hallmark of their philanthropy. Read More
Under the billing of Tall Orders, Dr. Murry raised the curtain on the profound potential of stem cells to change the way humans confront chronic disease. Watch the TEDxSeattle program here or read more about the landmark heart regeneration research underway at UW Medicine. Read More
Capillaries, the tiny but abundant vessels that enable the exchange of nutrients and waste, are so narrow that red blood cells must pass through in a single file line, making them challenging to study and prohibitively difficult to engineer. Until now. Read More
ISCRM faculty member Jen Davis is the new director of the UW Center for Cardiovascular Biology, an important ISCRM research partner. For the last decade Davis has been studying the role scarring plays in heart disease and in wound healing throughout the body.
